[Heterotopic contrast media excretion: excretion of bilivistan through the mucous membrane of the stomach and small intestine].
D002765:Cholecystography / Q000009:adverse effects*; D003287:Contrast Media / Q000378:metabolism*; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D007421:Intestine, Small; D008875:Middle Aged
D003287:Contrast Media
Heterotope Kontrastmittelausscheidung: Ausscheidung von Bilivistand durch Magen- und Dünndarmschleimhaut.